Gonorrhea Therapeutics Market - High Scope of Advancement with Curative Approach
Improved sensitivity of early diagnostic screening tools has highlighted grave concerns regarding the surge in gonorrhea incidences. As per a survey conducted by the Centers for Disease Control and Prevention, 555,608 cases of gonorrhea were reported in 2017, in the U.S., demonstrating an increase of 18.6% from 2009. These figures have hard-pressed the governments of numerous countries to take preventive and curative measures for relegating the prevalence of gonorrhea.
Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=36140
According to the gonorrhea therapeutics market research report published by Transparency Market Research (TMR), women are more susceptible to this disease than men, and the number of women availing therapeutics is on an exponential increase, thereby making women the key demographic of the market. The scramble of market players towards addressing the issue at the grass-root level has engendered several vaccines, including 4CMenB and rLP2086, which harbingers steady growth prospects for the landscape. However, literatures claiming the progressive resistance of gonorrhea to therapeutics could surface uncertainties regarding market advancement.
Women More Susceptible to Gonorrhea than Men', finds TMR Study
The connection of gonorrhea with infertility has accelerated the pace of research & development activities among market players to introduce effective therapeutics to combat this public health threat. A research team at the Louisiana State University Health Sciences discovered a novel antibiotic - zoliflodacin - to inhibit bacteria’s DNA synthesis with a differentiated approach than current antibiotics, which was well-received by the FDA, and the same has been marketed as an oral treatment for gonorrhea. Besides oral drugs, medical personnel recommend dual therapy over monotherapy, given the growing resistance of Neisseria Gonorrhoeae to antibiotics.
Request for Covid-19 Impact Analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=36140
A majority of women with gonorrhea show subtle signs of ongoing damage to the uterine tract, which, if left untreated, could cause involuntary infertility, ectopic pregnancy, or even chronic pelvic pain. As a result, this TMR study identifies that, the number of women availing gonorrhea therapeutics is projected to rise at a CAGR of ~6% during 2019-2027, with uncomplicated gonococcal infection being the leading cause.
Why Partnerships with Hospital Pharmacies Could be Profitable
The sales of gonorrhea therapeutics are projected to witness significant uptake from hospital pharmacies, as hospitals remain preferred care centers for patients diagnosed with gonorrhea. According to TMR’s estimates, hospital pharmacies will account for a value tantamount to ~US$ 548 Mn in 2019, out of which, ~37% of sales will come from hospital pharmacies based in North America alone.
Propitious environment for the growth of the healthcare sector in North America that is attributable to the intervention of the government in creating awareness regarding the prevalence of diseases, and hefty financial allocations for R&D activities are also likely to reflect on the advancement of the gonorrhea therapeutics market. Currently, North America monopolizes the gonorrhea therapeutics market; however, the Asia Pacific market holds profitable prospects on account of the growing sprawl of bacterial infections. On top of it, improvements in healthcare infrastructure coupled with financial lucidity of individuals has encouraged a large base to opt for effective gonorrhea therapeutics.
Buy Gonorrhea Therapeutics Market Report at - https://www.transparencymarketresearch.com/checkout.php?rep_id=36140<ype=S
Gonorrhea Therapeutics Market: Overview
· The global gonorrhea therapeutics market is projected to be valued at ~US$ 1.4 Bn in 2019, and expand at a CAGR of ~5.3% from 2019 to 2027. The rising prevalence of the disease and increasing use of new diagnostic tests are key factors that fuel the global gonorrhea therapeutics market.
· Gonorrhea is a sexually transmitted infection caused by a bacterium, and can be transmitted through sexual contact. All people who are sexually active may be at the risk of acquiring gonorrhea. Gonorrhea can infect the urethra (the tube that allows urine and semen to pass out of the body), cervix, rectum, throat, mouth, and eyes. Though, several people suffering from gonorrhea do not exhibit any symptoms.
· If symptoms do occur, they usually appear one to seven days after an infection. Symptoms can include vaginal pain, painful urination, and an abnormal discharge from the vagina, urethra, or rectum. Gonorrhea tests include obtaining samples from the sites of suspected infection and testing for the presence of the bacteria.
· Gonorrhea can be treated and cured using antibiotics; however, some strains of gonorrhea have become resistant to a few antibiotics. Gonorrhea can increase the risk of the sexual transmission of HIV.
Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=36140
· Gonorrhea can be transmitted through sexual intercourse. Transmission occurs when secretions from infected mucous membranes or semen of a person with a urethral infection come into contact with the mucous membranes of another person. Condom-less penetrative vaginal sex and anal sex are significantly high risk behaviors for the transmission of gonorrhea. Gonorrhea can be transmitted when a person who has an infection in the mouth or throat performs oral sex on another person, or when a person performs oral sex on a person who has a genital infection.
About Us Section:
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
